Treatment of idiopathic thrombocytopenic purpura.
ITP is a common disease that is sorely in need of better management. Treatment strategy requires consideration of both long-term benefits and long-term hazards of each available therapeutic option. This discussion reviews conventional therapy as well as newer approaches to refractory ITP, including immunosuppressants, vinca alkaloids, colchicine, androgens, tamoxifen, and plasmapheresis.
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D011696:Purpura, Thrombocytopenic / Q000276:immunology / Q000628:therapy*; D013156:Splenectomy; D014748:Vinca Alkaloids / Q000378:metabolism / Q000627:therapeutic use; D005719:gamma-Globulins / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D014748:Vinca Alkaloids; D005719:gamma-Globulins